Detalles de la búsqueda
1.
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
J Hypertens
; 26(3): 589-99, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18300872
2.
Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.
J Clin Hypertens (Greenwich)
; 9(10): 742-50, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17917501
3.
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension.
Hypertens Res
; 29(12): 997-1005, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17378372
4.
QTc interval prolongation associated with intravenous methadone.
Pain
; 105(3): 499-506, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14527710
5.
Efficacy, safety, and tolerability of aliskiren monotherapy administered with a light meal in elderly hypertensive patients: a randomized, double-blind, placebo-controlled, dose-response evaluation study.
J Clin Pharmacol
; 52(12): 1901-11, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22174431
6.
Antihypertensive treatment in patients with class 3 obesity.
Ther Adv Endocrinol Metab
; 3(3): 93-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23148200
7.
Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
J Clin Hypertens (Greenwich)
; 13(12): 889-97, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22142348
8.
Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients.
J Clin Hypertens (Greenwich)
; 13(7): 506-16, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21762364
9.
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Clin Drug Investig
; 31(12): 825-37, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22035463
10.
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
Cardiovasc Ther
; 28(6): 344-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406241
11.
Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskiren.
J Clin Pharmacol
; 50(12): 1358-66, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20150520
12.
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.
J Clin Hypertens (Greenwich)
; 12(10): 765-75, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21029339
13.
Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
Clin Ther
; 31(12): 2839-50, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20110023
14.
Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
Hypertens Res
; 32(3): 169-75, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19262478
15.
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
J Hypertens
; 27(7): 1493-501, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19444142
16.
Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
J Renin Angiotensin Aldosterone Syst
; 10(3): 157-67, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19617271
17.
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
J Renin Angiotensin Aldosterone Syst
; 9(3): 163-75, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18957387
18.
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
Circ Heart Fail
; 1(1): 17-24, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19808266
19.
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
Hypertension
; 49(5): 1047-55, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17353513
20.
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension.
J Am Coll Cardiol
; 49(11): 1157-63, 2007 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17367658